http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107854456-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0d44338a9983e0302c286cb9d319ff9 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 |
filingDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685253980351b754f8ecf6867157fabf |
publicationDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107854456-A |
titleOfInvention | Applications of the Heyneanones A in anti-anoxic medicine is prepared |
abstract | The invention discloses applications of the Heyneanones A in anti-anoxic medicine is prepared; pass through entirety and cellular level anoxia model; observe Heyneanones A oxygen lack resistant function; as a result show that Heyneanones A are remarkably improved survival rate and the time-to-live of asphyxia anoxia and acute decompression hypoxia mouse; mitigate the myocardial damage of drug specificity hypoxia mice; neonatal rat myocardial cell and nerve cell anoxia-induced apoptosis in vitro culture also have significant protective effect, there is provided purposes of the Heyneanones A in anti-anoxic medicine is prepared. |
priorityDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.